Vivaldis - About the company
Vivaldis is an acquired company based in Pune (India), founded in 2014 by Kunal Khanna. It operates as a Manufacturer of animal health care formulations and supplements. , with last known valuation of $*****. The company has 126 active competitors, including 20 funded and 22 that have exited. Its top competitors include companies like Ceva, Zoetis and Rejuvenate Bio.
Company Details
Vivaldis is an animal healthcare company that is involved in the care, cure, and management of companion animal health by introducing innovative and path-breaking treatment options. The products include a unique range of lifestyle disease management products & enzyme-based novel formulations, duly supported by routine formulations for infection & infestation control which maximize the health, agility, productivity, and performance of companion animals.
- Website
- vivaldis.co.in
- Email ID
- *****@vivaldis.co.in
- Phone Number
- +91 **********
- Registered Address
- OFFICE NO.803,CLOVER HILLS PLAZA, SN-27(PT) PL,KONDHWA, Pune, PUNE, Maharashtra, India, 411048
Key Metrics
Founded Year
2014
Location
Pune, India
Stage
Acquired
Last Known Valuation
$***** as on Mar 24, 2023
Ranked
12th among 126 active competitors
Annual Revenue
₹50 - ₹100 Cr as on Mar 31, 2025
Employee Count
137 as on Aug 31, 2025
Exit Details
Acquired by Sun Pharma (Mar 24, 2023)
Legal entities associated with Vivaldis
Vivaldis is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
VIVALDIS HEALTH AND FOODS PRIVATE LIMITED CIN: U24297PN2014PTC150393 , India, Active | Jan 31, 2014 | ₹50 - ₹100 Cr (As on Mar 31, 2025) | 137 (As on Aug 31, 2025) |
Vivaldis's acquisition details
Vivaldis got acquired by Sun Pharma on Mar 24, 2023 at an acquisition amount of $*****.
Click here to take a look at Vivaldis's acquisition in detail
Sign up to download Vivaldis' company profile
Vivaldis's funding and investors
Vivaldis has not raised any funding rounds yet.
Vivaldis' founders and board of directors
Founder? Claim ProfileThe founders of Vivaldis is Kunal Khanna. Kunal Khanna is the CEO of Vivaldis.
Here are the details of Vivaldis' key team members:
- Kunal Khanna: Founder & CEO of Vivaldis and founder of 1 other company. They are also an angel investor in 2 startups.Contact Info: 2 email addresses
View details of Vivaldis's Founder profiles and Board Members
Vivaldis' employee count trend
Vivaldis has 137 employees as of Aug 25. The total employee count is 1.0% lower than what it was in Aug 24. Here is Vivaldis's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Vivaldis's Competitors and alternates
Top competitors of Vivaldis include Ceva, Zoetis and Rejuvenate Bio. Here is the list of Top 10 competitors of Vivaldis, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Global animal health company providing innovative solutions for diverse animal species | $214M | 74/100 | ||
2nd | Zoetis 2013, Parsippany (United States), Public | Global animal health company dedicated to nurturing the world through animal care | - | 73/100 | |
3rd | Rejuvenate Bio 2018, San Diego (United States), Series A | Developer of gene therapies for treating chronic and age-related diseases | $34M | 62/100 | |
4th | Zenex Animal Health 2021, Ahmedabad (India), Seed | Manufacturer of veterinary drugs | $60.6K | 57/100 | |
5th | Hester Biosciences 1987, Ahmedabad (India), Public | Manufacturer of animal vaccines and healthcare products | - | 53/100 | |
6th | KindredBio 2012, Burlingame (United States), Acquired | Veterinary biotechnology company | $6.9M | 50/100 | |
7th | Biogenesis Bagó 2005, Garin (Argentina), Unfunded | Developer of therapeutics for animal health disorders | - | - | 47/100 |
8th | Developer of therapeutics for animal health | $2.5M | 46/100 | ||
9th | SpayVac 2018, Madison (United States), Seed | Developer of single-dose contraceptive vaccines for animal fertility control | $1M | 46/100 | |
10th | RR Animal Health Care 2006, Hyderabad (India), Funding Raised | Provider of vet pharmaceutical products | - | 46/100 | |
12th | Manufacturer of animal health care formulations and supplements | - | - | 44/100 |
Looking for more details on Vivaldis's competitors? Click here to see the top ones
Vivaldis's Investments and acquisitions
Vivaldis has made no investments or acquisitions yet.
Reports related to Vivaldis
Here is the latest report on Vivaldis's geography:
News related to Vivaldis
•
Sun Pharma announces agreement to acquire 60% of Vivaldis Health And FoodsZEE Business•Mar 24, 2023•Vivaldis, Sun Pharma
•
Sun Pharma acquires 60% stake in Vivaldis Health & Foods for ₹143 crLivemint•Mar 24, 2023•Sun Pharma, Vivaldis
•
Vivaldis Collaborates With Nutramax Laboratories Veterinary SciencesPR Newswire•Jul 30, 2018•Vivaldis, Nutramax Laboratories
Are you a Founder ?
FAQs about Vivaldis
Explore our recently published companies
- Mastercontrols - 1996 founded, Unfunded company
- Yingsuic - Unfunded company
- Sukrutaindia - 1966 founded, Unfunded company
- UseWok - France based, 2026 founded, Unfunded company
- Natural MedTech - Melbourne based, 2019 founded, Funding Raised company
- MPI - Benoni based, 1998 founded, Unfunded company